Warfarin pharmacogenetics: it matters if you're black or white.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Losartan does not inhibit cigarette smoke-induced lung inflammation in mice.Scientific reports · 2019
   Article
2. Concepts Driving Pharmacogenomics Implementation Into Everyday Healthcare.Pharmacogenomics and personalized medicine · 2019
   Review
3. VKORC1-1639A allele influences warfarin maintenance dosage among Blacks receiving warfarin anticoagulation: a retrospective cohort study.Future cardiology · 2018
   Article
4. How to implement pre-emptive pharmacogenetic testing in the acute hospital setting.Pharmacogenomics
   Review

Corrections and comments

• Comment on
  Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans.2014

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as